Clinical Trial Detail

NCT ID NCT03850574
Title Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM43239 in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Hanmi Pharmaceutical Company Limited
Indications

acute myeloid leukemia

Therapies

HM43239

Age Groups: adult senior

No variant requirements are available.